MARKET

MRK-WI

MERCK & CO
MRK-WI
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
26.97
3.961
7.05
189,904,377,300.00
LIVE MARKETS-Big pharma goes on a shopping spree
Reuters · 1d ago
Merck starts pivotal Phase 2b/3 MALBEC trial of MK-8748 for wet AMD
Reuters · 1d ago
EU approves Merck Keytruda-paclitaxel regimen for PD-L1+ platinum-resistant ovarian cancer
Reuters · 1d ago
EUROPEAN COMMISSION APPROVES KEYTRUDA® (PEMBROLIZUMAB) PLUS PACLITAXEL ± BEVACIZUMAB FOR THE TREATMENT OF ADULTS WITH PD-L1 (CPS ≥1) PLATINUM-RESISTANT RECURRENT OVARIAN CARCINOMA WHO HAVE RECEIVED ONE OR TWO PRIOR SYSTEMIC TREATMENT REGIMENS
Reuters · 1d ago
Merck to host first-quarter sales and earnings conference call
Reuters · 2d ago
INFINIMMUNE: UNDER AGREEMENT, MERCK WILL HAVE EXCLUSIVE RIGHT TO DEVELOP AND COMMERCIALIZE ANTIBODY CANDIDATES
Reuters · 3d ago
INFINIMMUNE: ELIGIBLE TO RECEIVE MILESTONE PAYMENTS FROM MERCK ASSOCIATED WITH PROGRESS OF MULTIPLE ANTIBODY CANDIDATES TOTALING UP TO ABOUT $838 MLN
Reuters · 3d ago
INFINIMMUNE ENTERS COLLABORATION WITH MERCK TO DISCOVER NOVEL HUMAN ANTIBODY THERAPEUTICS
Reuters · 3d ago
More

Webull offers MERCK & CO stock information, including NYSE: MRK-WI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK-WI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK-WI stock methods without spending real money on the virtual paper trading platform.